Tag: Cancer

BEER-SHEVA, Israel and BINYAMINA, Israel, May 4, 2023 /PRNewswire/ — OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced that it has signed an option agreement with BGN Technologies, the technology transfer company of Ben-Gurion University of the Negev (BGU), to receive a license for a novel biosensing technology called IcAR (Immuno-checkpoint Artificial Reporter). IcAR was developed by a team of researchers from BGU. Read...

Artificial intelligence and machine learning could change the face of cancer diagnostics. Today, physicians may run blood tests to find biomarkers specific to cancer, conduct imaging tests via MRI, CT or ultrasound to visualize a potential tumor or biopsy to analyze tissue up close. Read...

BINYAMINA, Israel, Feb. 1, 2023 /PRNewswire/ — OncoHost, a precision diagnostics company centered on predictive biomarker development for improved patient care, today announced the official launch of its PROphet® non-small lung cancer (NSCLC) Test in the United States. Read...

BINYAMINA, Israel , Jan. 11, 2023 /PRNewswire/ — OncoHost, a global leader in next-generation precision oncology for improved personalized cancer therapy, today announced that its PROphet® platform has been named a winner in the healthcare category of the 2023 BIG Innovation Awards presented by the Business Intelligence Group. Read...

Two prestigious research institutes, Baylor Scott and White Health and the Translational Genomics Research Institute (TGen), announced today a new research study aimed at analyzing cancer resistance mechanisms using several multiomics technologies, in collaboration with Israeli startup OncoHost Read...